Point-of-care diagnostics is outlined as medical diagnostic testing at the place of the incident or close to the point of care i.e. at the time and place of patient care. This contrasts with the historical pattern during which testing was entirely or principally confined to the medical laboratory, that entailed causation of specimens off from the point of care and then by waiting hours or days to find out the results, during which time care should continue without having the required data.
The Middle-East & Africa Point-of-care Diagnostics Market is estimated to have a value of USD 1.51 billion in 2016. The market size is anticipated to grow rapidly with a CAGR of 9.42%, to reach a value of USD 2.36 billion by 2021. Apart from the increased incidence of target diseases, factors such as growing government initiatives supporting the adoption of POC diagnostic products are driving the growth in this market.
The biggest share by volume of the market is commandeered by the infectious disease testing products segment. This growth in this product category can be related to factors such as increasing number of patient individuals and growing awareness about infectious disease POC testing products.
An augmented range of geriatric population in these regions requiring quick testing of various health problem at home settings is strengthening the demand for such care systems. The escalating demand for diagnostic units for higher maternity well-being in numerous developing economies is likewise supporting the demand for point-of-care testing in this region.
As of now, Middle Eastern countries is projected to grow at a stable rate due to an increasing patient base. The major market contributors for the Middle-East & Africa Point-of-care Diagnostics Market are Abbott Laboratories Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics.
The scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence Equip you with the information providing with the investment opportunities in the industry
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
